Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky
针对肯塔基州农村地区注射毒品者的综合 PrEP 干预措施
基本信息
- 批准号:10452614
- 负责人:
- 金额:$ 31.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAddressAdministratorAmericasAppalachian RegionCaringCase ManagementCenters for Disease Control and Prevention (U.S.)ClientClinicalCollaborationsCountyDataDisease OutbreaksDrug userEducationEnvironmentEpidemicEquipmentEvidence based interventionGuidelinesHIVHIV InfectionsHIV diagnosisHarm ReductionHuman immunodeficiency virus testIncidenceIndianaIndividualInfrastructureInjecting drug userInjectionsInterventionInterviewKentuckyKnowledgeLiteratureLocationMeasuresMedicalMonitorNeedle-Exchange ProgramsNorth CarolinaParticipantPharmaceutical PreparationsPractical Robust Implementation and Sustainability ModelPreventionProtocols documentationProviderRandomizedRiskRuralRural CommunityService delivery modelServicesSiteSterilityStructureSyringesTestingUnited StatesWest VirginiaWomanWorkacceptability and feasibilitybarrier to carebasebrief interventionclinical caredrug testingevidence basehealth care availabilityhigh riskinformantinjection drug usemennovelopioid epidemicpoint of carepre-exposure prophylaxisprevention servicepreventive interventionprimary outcomerisk perceptionrural areasatisfactionscale upscreeningservice interventionservice providerssocial stigmastimulant usetooltransmission processuptake
项目摘要
ABSTRACT
Rural areas in the United States are increasingly impacted by HIV, tied to the ongoing opioid epidemic,
growing stimulant use, and widespread drug injection. Kentucky (KY) is among seven states identified with
heavy rural HIV burden and increasing rates of new HIV diagnoses attributable to injection drug use. Rural
HIV outbreaks among people who inject drugs (PWID) have occurred recently in KY’s neighboring states,
highlighting the urgent need to implement proven HIV prevention and harm reduction strategies for PWID in
KY’s rural areas. A key pillar of Ending the HIV Epidemic (EHE): A Plan for America is the prevention of new
HIV infections through scale up of evidence-based interventions, including syringe service programs (SSPs)
and Pre-exposure prophylaxis (PrEP). Our R21 in KY’s Appalachian region demonstrated consistent utilization
of rurally located SSPs by high-risk PWID, making SSPs a critical venue to scale delivery of comprehensive
HIV prevention services in rural areas. In a prior RCT conducted by the PI of this application, strengths-based
case management (SBCM) interventions were shown to be effective in increasing HIV testing and overcoming
barriers to medical care among people who use drugs. Building on this prior work and ongoing collaboration
with rural SSPs in KY, this R34 will adapt and integrate a novel PrEP initiation intervention at point of
care in rural SSPs, in two KY counties that are among the nation’s top 10 most vulnerable to HIV
among PWID, and conduct a preliminary test of its efficacy. The Specific Aims are to: 1) Assess client,
provider, organization, and structural-level facilitators and barriers to integration of a PrEP focused
SBCM (SBCM-PrEP) intervention into routine SSP practice. Guided by the PRISM model, we will conduct
semi-structured key informant interviews with PWID, clinical care and harm reduction service providers, and
facility administrators in our targeted SSP implementation locations, to identify individual, organizational, and
structural challenges and opportunities to adapt the SBCM-PrEP to enhance client acceptability, accessibility
and compatibility with clinical workflow; 2) Adapt an evidence-based SBCM protocol to provide PrEP
intervention services for PWID in SSP sites. Using in-depth interview data from Aim 1, we will adapt, refine
and incorporate HIV prevention content most salient to PrEP care into the SBCM-PrEP, following the ADAPT
ITT framework; and 3) Examine feasibility, acceptability and preliminary efficacy of the adapted SBCM-
PrEP. 80 participants will be randomized into: CDC-PrEP (an in-use PrEP intervention based on CDC
guidelines), or SBCM-PrEP. Primary outcomes include feasibility and acceptability (measured by intervention
attendance, engagement, and satisfaction) during the active intervention period, and preliminary efficacy on
PrEP initiation (measured by dispensed PrEP prescription) 3- and 6- months post-baseline. The proposed
study fills a gap in evidence for PrEP studies among rural PWID by testing brief interventions that address both
individual and structural challenges to PrEP uptake through an integrated, point of care service delivery model.
摘要
美国农村地区日益受到艾滋病毒的影响,与持续的阿片类药物流行有关,
越来越多的兴奋剂使用,以及广泛的毒品注射。肯塔基州(KY)是被认定为
农村艾滋病毒负担沉重,注射吸毒导致的艾滋病毒新诊断率不断上升。农村
注射吸毒者(PWID)中的艾滋病毒疫情最近在肯塔基州的邻国发生,
强调迫切需要在#年为残疾人实施行之有效的艾滋病毒预防和减少危害战略
肯塔基州的农村地区。结束艾滋病毒流行(EHE)的关键支柱:美国的计划是预防新的
通过扩大循证干预措施,包括注射器服务计划(SSP),感染艾滋病毒
和暴露前预防(PrEP)。我们在肯塔基州阿巴拉契亚地区的R21显示出持续的利用率
通过高风险PWID对农村地区的SSP进行分析,使SSP成为扩展全面交付的关键场所
农村地区的艾滋病毒预防服务。在此应用程序的PI执行的先前RCT中,基于优势
病例管理(SBCM)干预措施被证明在增加艾滋病毒检测和克服艾滋病毒方面有效
吸毒者的医疗保健障碍。以之前的工作和持续的协作为基础
随着肯塔基州的农村SSP,R34将在以下点调整和集成新的PrEP启动干预
在肯塔基州两个县的农村SSP提供护理,这两个县是全国最容易感染艾滋病毒的十大县之一
并对其疗效进行初步测试。具体目标是:1)评估客户,
专注于PrEP的提供商、组织和结构级别的促进者和集成障碍
常规SSP实践中的SBCM(SBCM-PrEP)干预。在棱镜模式的指导下,我们将进行
对PWID、临床护理和减少伤害服务提供商的半结构化关键线人访谈,以及
我们目标SSP实施地点的设施管理员,以确定个人、组织和
调整SBCM-PrEP以提高客户可接受性、可获得性的结构性挑战和机遇
并与临床工作流程兼容;2)采用基于循证的SBCM协议提供PrEP
SSP站点的PWID干预服务。使用来自目标1的深度访谈数据,我们将适应、改进
并将PrEP护理最突出的艾滋病毒预防内容纳入SBCM-PrEP
ITT框架;以及3)检查调整后的SBCM的可行性、可接受性和初步效果-
准备好了。80名参与者将被随机分为:CDC-PrEP(基于CDC的正在使用的PrEP干预
指南),或SBCM-PrEP。主要结果包括可行性和可接受性(通过干预来衡量
出勤率、参与度和满意度),以及初步疗效
基线后3个月和6个月开始准备(由配发的PrEP处方测量)。建议数
研究填补了农村PWID中PrEP研究的证据空白,测试了解决这两个问题的简短干预措施
通过集成的护理点服务交付模式,PrEP的个人和结构性挑战。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HILARY L SURRATT其他文献
HILARY L SURRATT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HILARY L SURRATT', 18)}}的其他基金
Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky
针对肯塔基州农村地区注射毒品者的综合 PrEP 干预措施
- 批准号:
10320665 - 财政年份:2021
- 资助金额:
$ 31.2万 - 项目类别:
Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky
针对肯塔基州农村地区注射毒品者的综合 PrEP 干预措施
- 批准号:
10670122 - 财政年份:2021
- 资助金额:
$ 31.2万 - 项目类别:
Examining Social Influences on Syringe Exchange Uptake among Rural PWID at Risk for HIV
检查社会对有艾滋病毒风险的农村吸毒者更换注射器的影响
- 批准号:
9481503 - 财政年份:2017
- 资助金额:
$ 31.2万 - 项目类别:
The Diversion of Antiretroviral Medications to Street Markets
抗逆转录病毒药物转移到街头市场
- 批准号:
8223567 - 财政年份:2008
- 资助金额:
$ 31.2万 - 项目类别:
The Diversion of Antiretroviral Medications to Street Markets
抗逆转录病毒药物转移到街头市场
- 批准号:
8329025 - 财政年份:2008
- 资助金额:
$ 31.2万 - 项目类别:
The Diversion of Antiretroviral Medications to Street Markets
抗逆转录病毒药物转移到街头市场
- 批准号:
7741733 - 财政年份:2008
- 资助金额:
$ 31.2万 - 项目类别:
The Diversion of Antiretroviral Medications to Street Markets
抗逆转录病毒药物转移到街头市场
- 批准号:
7580136 - 财政年份:2008
- 资助金额:
$ 31.2万 - 项目类别:
The Diversion of Antiretroviral Medications to Street Markets
抗逆转录病毒药物转移到街头市场
- 批准号:
8013055 - 财政年份:2008
- 资助金额:
$ 31.2万 - 项目类别:
HIV/AIDS PREVENTION RESEARCH IN ST.CROIX,U.S. V.I.
美国圣克罗伊岛的艾滋病毒/艾滋病预防研究
- 批准号:
6589920 - 财政年份:2002
- 资助金额:
$ 31.2万 - 项目类别:
HIV/AIDS PREVENTION RESEARCH IN ST.CROIX,U.S. V.I.
美国圣克罗伊岛的艾滋病毒/艾滋病预防研究
- 批准号:
6667086 - 财政年份:2002
- 资助金额:
$ 31.2万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Research Grant














{{item.name}}会员




